The Korean Journal of Gastroenterology (대한소화기학회지)

The Korean Society of Gastroenterology (대한소화기학회)
권호 표지

Prevalence, Clinical Manifestations, and Treatment of Gastroesophageal Reflux Disease in Korea

우리 나라에서 위식도역류질환의 빈도, 임상 양상 및 치료

Jeon, Seong-Gook;Rhee, Poong-Lyul
전성국;이풍렬

  • Published : 20020600
⟨ Previous Next ⟩

Abstract

Department of Internal Medicine, SungkyunGastroesophageal reflux disease (GERD) is characterized by the presence of esophageal mucosal injury or by the occurrence of reflux-induced symptoms which are severe enough to impair quality of life. GERD is a common GI disorder in the West, but not in the East including Korea. Heartburn is the most common symptom of GERD in the West, but it is rare in a substantial proportion of patients with GERD in Korea. Epigastric soreness or pain of Korean patients could result from gastroesophageal reflux. The suppression of acid is the mainstay of therapy for GERD. Proton pump inhibitors can be an attractive choice of initial treatment because of rapid symptom relief and healing of esophagitis. Because GERD is a chronic relapsing disorder, most of patients require long-term management. For long-term management of GERD, step-down approach is recommendable considering clinical and economic effectiveness.

Keywords

References

  1. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831 https://doi.org/10.1056/NEJM199903183401101
  2. Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakk M, Keyrilainen O. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997;92:37-41
  3. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut 1999;44(suppl 2):1S-16S https://doi.org/10.1136/gut.44.2008.S1
  4. Dent J. Definitions of reflux disease and its separation from dyspepsia. Gut 2002;50(suppl 4):17S-20S https://doi.org/10.1136/gut.50.suppl_2.a17
  5. 윤영호, 강영우, 안성훈, 박승국. 최근 역류성 식도염의 유병률 변화-건강 검진자군과 소화기 증상군을 대상으로- 대한소화기내시경학회지 2001;23:144-148
  6. 정성애, 정훈용, 김기락, 민영일. 1990년대 한국 성인에서 역류성 식도염의 유병률 변화. 대한소화관운동학회지 2001;7:161-167
  7. Eisen G. The epidemiology of gastroesophageal reflux disease: what we know and what we need to know. Am J Gastroenterol 2001;96(suppl):16S-18S https://doi.org/10.1111/j.1572-0241.2001.03447.x
  8. Talley NJ, Zinsmeister AR, Schleck CD, et al. The natural history of gastroesophageal reflux. Gastroenterology 1992;102(abstr):28A
  9. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Sci 1976;21:953-956 https://doi.org/10.1007/BF01071906
  10. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted county, Minnesota. Gastroenterology 1997;112:1448-1456 https://doi.org/10.1016/S0016-5085(97)70025-8
  11. Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998;42:690-695 https://doi.org/10.1136/gut.42.5.690
  12. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998;93:1816-1822 https://doi.org/10.1111/j.1572-0241.1998.00526.x
  13. 전성국, 손정일, 김지은 등. 성인 건강 검진자에서 위식도 역류 증상의 빈도. 대한내과학회지 2000;58:145-151
  14. 추교영, 최명규, 박수헌 등. 우리나라 위식도역류 증상의 유병률: 표본인구 설문조사. 대한소화관운동학회지 2001;7(abstr):88
  15. Carteret E, Pasqual JC, Renard P, Zeitoun P. Frequency and prognosis of erosive reflux esophagitis. Gastroenterology 1988;94(abstr):61A
  16. Berstad A, Weberg R, Froyshov Larsen I, Hoel B, Hauer-Jensen M. Relationship of hiatus hernia to reflux esophagitis. A prospective study of coincidence, using endoscopy. Scand J Gastroenterol 1986;21:55-58
  17. Rasmussen CW. A new endoscopic classification of chronic esophagitis. Am J Gastroenterol 1976;65:409-415
  18. Stoker DL, Williams JG, Leicester RG, Colin JDG. Oesophagitis-a five year review. Gut 1988;29(abstr):1450A
  19. Chang CS, Poon SK, Lien HC, Chen GH. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol 1997;92:668-671
  20. Kang JY, Tay HH, Yap I, Guan R, Lim KP, Math MV. Low frequency of endoscopic esophagitis in Asian patients. J Cin Gastroenterol 1993;16:70-73 https://doi.org/10.1097/00004836-199301000-00019
  21. Furukawa N, Iwakiri R, Koyama T, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gasttorenterol 1999;34:441-444 https://doi.org/10.1007/s005350050293
  22. Yeh C, Hsu C, Ho AS, Sampliner RE, Fass R. Erosive esophagitis and Barrett's esophagus in Taiwan: a high frequency than expected. Dig Dis Sci 1997;42:702-706 https://doi.org/10.1023/A:1018835324210
  23. 이선영, 이성구, 김명환, 한동수, 김정원, 민영일. 건강검진자의 역류성 식도염에 대한 임상적 고찰. 대한내과학회지1994;46:514-520
  24. 전성국, 이풍렬, 신명희 등. 건강 검진자에서 역류성 식도염의 유병률 및 위험 인자에 대한 환자-대조군 연구. 대한소화기학회지 1998;32:701-708
  25. Lee SJ, Song CW, Jeen YT, et al. Prevalence of endoscopic reflux esophagitis among Koreans. J Gastroenterol Hepatol 2001;16:373-376 https://doi.org/10.1046/j.1440-1746.2001.02464.x
  26. 임병철, 정훈용, 박무인 등. 한국인에서 식도 열공 hernia와 역류성 식도염의 유병률 및 상관 관계에 관한 연구. 대한소화기내시경학회지 1999;19(suppl 3):54S
  27. 나용호, 장명규, 유재규, 송승렬. 위식도 역류질환에서 식도염의 발현율. 대한소화기내시경학회지 1994;14:145-150
  28. 이숭, 김형주, 이경록 등. 식도열공헤르니아와 역류성 식도염의 임상적 고찰-비만, 음주, 흡연, 커피, H. pylori 감염과의 관계- 대한소화기내시경학회지 1999;19:861-868
  29. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-1029 https://doi.org/10.1080/003655298750026697
  30. Johnsson F, Roth Y, Damgaard Pedersen NE, Joelsson B. Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Aliment Pharmacol Ther 1993;7:81-86
  31. 이성희, 최명규, 추교영 등. 우리나라 위식도역류질환의 임상상. 대한소화관운동학회지 2000;6:1-10
  32. 김윤배, 송치욱, 김혜랑 등. 속쓰림을 호소하는 환자에서 위식도역류질환의 빈도 및 주석산 시사프리드의 효과에 대한 연구. 대한소화관운동학회지 2000;6:188-195
  33. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101(suppl):1S-78S
  34. McNally PR, Maydonovitch CL, Prosek RS, Collette RP, Wong RK. Evaluation of gastroesophageal reflux as a cause of idiopathic hoarseness. Dig Dis Sci 1989;34:1900-1904 https://doi.org/10.1007/BF01536709
  35. 최명규, 문성배, 김보경 등. 만성적인 후두증상을 호소하는 환자에서 위식도역류. 대한소화관운동학회지 1998;5:105-111
  36. Harding SM, Richter JE. Gastroesophageal reflux disease and asthma. Semin Gastrointest Dis 1992;3:139-150
  37. Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981;123:413-417
  38. Davies HA, Jones DB, Rhodes J, Newcombe RG. Angina-like esophageal pain: differentiation from cardiac pain by history. J Clin Gastroenterol 1985;7:477-483 https://doi.org/10.1097/00004836-198512000-00007
  39. Vantrappen G, Janssens J, Ghillebert G. The irritable oesophagus-a frequent cause of angina-like pain. Lancet 1987;30:1232-1234
  40. Orr WC, Allen ML, Robinson M. The pattern of nocturnal and diurnal esophageal acid exposure in the pathogenesis of erosive mucosal damage. Am J Gastroenterol 1994;89:509-512
  41. Robertson D, Aldersley M, Shepherd H, Smith CL. Patterns of acid reflux in complicated oesophagitis. Gut 1987;28:1484-1488 https://doi.org/10.1136/gut.28.11.1484
  42. DeMeester TR, Johnson LF, Joseph GJ, Toscano MS, Hall AW, Skinner DB. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976;184:459-470 https://doi.org/10.1097/00000658-197610000-00009
  43. 장데레사, 김백선, 김선명 등. 위식도역류질환 환자에서 산역류의 양상. 대한소화관운동학회지 2000;6:173-179
  44. DeVault KA, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999;94:1434-1442 https://doi.org/10.1111/j.1572-0241.1999.1123_a.x
  45. Tytgat GN, Janssens J, Reynolds JC, Wienbeck M. Update on the pathophysiology and management of gastroesophageal reflux disease: the role of prokinetic therapy. Eur J Gastroenterol Hepatol 1996;8:603-611 https://doi.org/10.1097/00042737-199606000-00020
  46. Geldof H, Hazelhoff B, Otten MH. Two different dose regimens of cisapride in the treatment of reflux esophagitis: a double-blind comparison with ranitidine. Aliment Pharmacol Ther 1993;7:409-415
  47. Hatlebakk JG, Berstad A. Gastroesophageal reflux during 3 months of therapy with ranitidine oesophagitis. Scand J Gastroenterol 1886;31:954-958 https://doi.org/10.3109/00365529609003113
  48. Chiba N, DeGara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997;112:1798-1810 https://doi.org/10.1053/gast.1997.v112.pm9178669
  49. Bell NJ, Hunt RH. Role of gastric acid suppression in the treatment of gastroesophageal reflux disease. Gut 1992;33:118-124 https://doi.org/10.1136/gut.33.1.118
  50. Dent J, Jones R, Kahrilas P, Talley NJ. Management of gastro-oesophageal reflux disease in general practice. BMJ 2001;322:344-347 https://doi.org/10.1136/bmj.322.7282.344
  51. Ofman JJ, Dorn GH, Fennerty MB, Fass R. The clinical and economic impact of competing management strategies for gastroesophageal reflux disease. Aliment Pharmacol Ther 2002;16:261-273 https://doi.org/10.1046/j.1365-2036.2002.01167.x
  52. Carlsson R, Galmiche JP, Dent J, Lundell L, Frison L. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther 1997;11:473-482 https://doi.org/10.1046/j.1365-2036.1997.00167.x
  53. Dent J. Management of reflux disease. Gut 2002;50(suppl 4):67S-71S https://doi.org/10.1136/gut.50.suppl_2.a67
  54. Carlsson R, Dent J, Watts R, et al. Gastro-oesohageal reflux disease (GORD) in primary care-an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998;10:119-124 https://doi.org/10.1097/00042737-199802000-00004
  55. Bardhan KD, Muller-Lissner S, Bigard MA, et al. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. BMJ 1999;318:502-507 https://doi.org/10.1136/bmj.318.7182.502
  56. Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux diseas in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 1992;326:786-792 https://doi.org/10.1056/NEJM199203193261202
  57. Lundell L, Miettinen P, Myrvold HE, et al. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 2001;192:172-179 https://doi.org/10.1016/S1072-7515(00)00797-3